mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.04 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.094 |
0.04 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.04 |